Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Br J Haematol. 2021 May 24;193(6):1142–1150. doi: 10.1111/bjh.17534

Figure 2.

Figure 2.

The frequency of mutations in different genes in women and men across the different phenotypes (MDS/MPN-RS-T: MDS/MPN with ring sideroblasts and thrombocytosis, MDS/MPN-U: MDS/MPN-unclassifiable, CMML: chronic mylelomonocytic leukemia, aCML: atypical CML). The high-risk genes are indicated in squares.